市場調查報告書
商品編碼
1403528
肛門測壓系統的全球市場至2030年的預測:按產品類型、醫療器材類型、最終用戶和地區分析Anorectal Manometry Systems Market Forecasts to 2030 - Global Analysis By Product Type, Modality Type, End User and by Geography |
根據 Stratistics MRC 的資料,2023年全球肛門測壓系統市場規模為 7,822 萬美元,預計到2030年將達到 1.4326 億美元,預測期內年複合成長率為 9.03%。
肛門測壓系統對於評估和診斷肛門區域相關狀況非常重要。透過測量直腸和肛管的壓力和肌肉功能,這些基於先進技術的系統為骨盆底功能障礙、大便失禁和便秘等疾病提供了重要的新見解。將帶有壓力感測器的導管插入直腸,以精確測量各種運動(例如耐力或放氣)期間的肌肉收縮和協調性。
根據國家健康和營養檢查調查(NHANES)的估計,僅在美國, 8.3%的非收容人員患有大便失禁(FI)。男性和女性的 FI 盛行率相似(7.7%vs. 8.9%)。
肛門測壓系統的採用主要是由於久坐的生活方式、飲食變化和高齡化引起的肛門疾病的日益流行。越來越多的人出現骨盆底功能障礙、大便失禁和便秘等症狀,需要準確的診斷工具進行早期療育和有針對性的治療計劃。此外,肛門測壓系統為盡可能最佳的患者照護提供準確的資訊,人們越來越認知到這些疾病是導致患者發病的主要原因,這證明了這一點。它在提供診斷見解方面發揮著重要作用。
由於取得和維護肛門測壓系統的初期成本較高,醫療機構面臨財務挑戰。運行和分析這些系統的輸出需要專門的培訓和技術知識,增加了資源需求。此外,在某些醫療保健環境中,實施這些系統的成本可能令人望而卻步,尤其是那些資源和衛生預算有限的環境。
持續的技術進步帶來了改善肛門測壓系統的功能和易用性的機會。創新包括更好的導管設計、方便用戶使用的介面以及與人工智慧(AI)整合以進行即時資料分析。此外,這種類型的改進可以簡化流程,緩解醫療保健專業人員的學習曲線,並提高肛門測壓的一般診斷準確性和有效性。
糞便檢測、磁振造影(MRI)和大腸是對肛門測壓系統構成威脅的既定替代診斷方法。儘管出於患者舒適度、可及性和熟悉度等原因,醫療保健專業人員可能會繼續青睞這些試驗的技術,儘管它們各自有優點和缺點。此外,肛門測壓系統的廣泛普及受到替代診斷技術競爭的威脅。
肛門測壓系統市場受到了 COVID-19大流行的各種影響。將資源集中在應對疫情上導致了製造、供應鏈和選擇性醫療程序的早期中斷,但後來凸顯了市場的彈性和適應性。此外,由於疫情和遠端醫療行業的迅速普及,人們對肛門健康的認知不斷增強,導致向遠端患者監護的轉變,肛門測壓系統有可能整合到遠端醫療平台中。
預計獨立式肛門測壓系統將佔據最大的市場佔有率。其豐富的功能集和對詳細診斷評估的適用性使這些系統成為專業配備的臨床環境的可行選擇。憑藉其強大的功能和先進的功能,獨立系統可以在徹底的資料收集和分析非常重要的情況下處理各種診斷場景。此外,在傳統臨床環境中提供準確評估肛門功能的既定能力導致市場佔有率的增加。
由於診斷程序的針對性方法以及外包專業測試的成長趨勢,診斷中心產業預計將表現出最高的年複合成長率。診斷中心提供專業服務,等待時間更短,並配備肛門測壓系統等最尖端科技,對尋求準確診斷評估的患者更具吸引力。此外,診斷中心是一個快速成長的行業,因為它們透過專門從事診斷來簡化工作流程並提高效率。
預計肛門測壓系統市場將佔據北美地區的最大佔有率。該地區的優勢包括先進醫療技術採用較早、胃腸道疾病患病率較高、醫療基礎設施發達。此外,由於存在重要的市場參與者,持續的研發努力以及強大的法律規範,北美在肛門測壓系統市場中佔據了重要佔有率。
預計歐洲地區的年複合成長率最高。該地區顯著的市場佔有率歸因於先進的診斷技術、先進的醫療基礎設施和胃腸道疾病的高發病率。歐洲對醫療保健研究和開發的高度重視以及有利的償付政策使其成為肛門診斷創新的中心。此外,歐盟採用先進的醫療技術和提高肛門健康意識是推動該地區肛門測壓系統顯著成長的兩個因素。
According to Stratistics MRC, the Global Anorectal Manometry Systems Market is accounted for $78.22 million in 2023 and is expected to reach $143.26 million by 2030 growing at a CAGR of 9.03% during the forecast period. Anorectal manometry systems are essential for the evaluation and diagnosis of conditions pertaining to the anorectal area. By measuring pressure and muscle function in the rectum and anal canal, these advanced technology-based systems offer important new insights into conditions like pelvic floor dysfunction, fecal incontinence, and constipation. A catheter equipped with pressure sensors is inserted into the rectum during the procedure to measure muscle contractions and coordination precisely during different exercises, like bearing down and squeezing.
According to the National Health and Nutrition Examination Survey's (NHANES) estimations, 8.3% of non-institutionalized people in the USA alone have faecal continence (FI). Men and women both had a similar prevalence of FI (7.7% vs. 8.9%).
Adoption of anorectal manometry systems is primarily driven by the rising prevalence of anorectal disorders, which are caused by sedentary lifestyles, dietary changes, and aging demographics. A growing number of people are experiencing conditions like pelvic floor dysfunction, fecal incontinence, and constipation, which make precise diagnostic tools necessary for early intervention and focused treatment plans. Additionally, anorectal manometry systems play a critical role in providing accurate diagnostic insights for the best possible patient care, as evidenced by the increasing recognition of these disorders as major contributors to patient morbidity.
Healthcare facilities face financial difficulties due to the high initial costs of acquiring and maintaining anorectal manometry systems. The resource intensity is increased by the requirement for specific training and technical know-how to run and analyze the output from these systems. Furthermore, in certain healthcare settings, especially those with limited resources or healthcare budgets, the cost of implementing these systems may be prohibitive.
Opportunities to improve the functionality and usability of anorectal manometry systems are presented by ongoing technological advancements. Innovations include better catheter designs, user-friendly interfaces, and integration with artificial intelligence (AI) for real-time data analysis. Moreover, improvements of this kind can simplify processes, lessen the learning curve for medical professionals, and raise the general diagnostic accuracy and effectiveness of anorectal manometry.
Defecagraphy, magnetic resonance imaging (MRI), and colonoscopy are among the well-established alternative diagnostic modalities that pose a threat to anorectal manometry systems. Healthcare professionals may continue to favor these tried-and-true techniques despite their own advantages and disadvantages due to things like patient comfort, accessibility, and familiarity. Additionally, the widespread use of anorectal manometry systems is threatened by competition from alternative diagnostic techniques.
The anorectal manometry systems market has been impacted by the COVID-19 pandemic in a number of ways. While lockdowns and the focus of resources on pandemic response caused disruptions in manufacturing, supply chains, and elective medical procedures in the early stages, the market's resilience and adaptability were brought to light in the later stages. Furthermore, anorectal manometry systems have the potential to be integrated into telehealth platforms due to the shift towards remote patient monitoring brought about by the pandemic's increased awareness of anorectal health and the telemedicine industry's rapid adoption.
It is projected that stand-alone anorectal manometry systems will command the largest market share. These systems have been the go-to option in clinical settings with specialized facilities because of their extensive feature set and suitability for in-depth diagnostic evaluations. With their robust capabilities and advanced functionalities, stand-alone systems can handle a wide range of diagnostic scenarios in situations where thorough data collection and analysis are critical. Moreover, their greater market share is a reflection of their well-established ability to provide accurate assessments of anorectal function in conventional clinical settings.
Due to the targeted approach to diagnostic procedures and the growing trend of outsourcing specialized tests, the diagnostic center segment is expected to have the highest CAGR. Diagnostic centers are more appealing to patients looking for accurate diagnostic evaluations because they offer specialized services with shorter wait times and are outfitted with cutting-edge technologies like anorectal manometry systems. Additionally, diagnostic centers are a rapidly growing segment due to their streamlined workflow and specialization in diagnostics, which enhance efficiency.
The market for anorectal manometry systems is expected to have the largest share in the North American region. The region's early adoption of cutting-edge medical technologies, high prevalence of gastrointestinal disorders, and well-established healthcare infrastructure are all contributing factors to its dominance. Furthermore, the substantial market share held by North America in the anorectal manometry systems market is further attributed to the existence of important market players, continuous research and development efforts, and a strong regulatory framework.
Europe region is projected to have the highest CAGR. The region's noteworthy market share can be attributed to its advanced diagnostic technologies, sophisticated healthcare infrastructure, and high incidence of gastrointestinal disorders. Europe is a center for innovation in anorectal diagnostics because of its dedication to healthcare R&D and its advantageous reimbursement policies. Moreover, the European Union's adoption of advanced medical technologies and growing consciousness of anorectal health are two factors driving the significant growth of anorectal manometry systems in the region.
Some of the key players in Anorectal Manometry Systems market include Laborie Medical Technologies, Medtronic plc, Sierra Scientific Instruments, Albyn Medical S.L., InnovaStar, MMS Medical Measurement Systems B.V., Oakworks Med, Schuster Medizin-Technik GmbH and Medspira.
In September 2023, Laborie Medical Technologies has entered a definitive agreement for the acquisition of medical device company Urotronic in a deal valued at up to $600m. As per the deal, Laborie will make an upfront cash payment of $255m to Urotronic. Urotronic is entitled to receive potential commercial and reimbursement milestone payments of up to an additional $345m.
In May 2023, Medtronic plc, a global leader in healthcare technology, today announced it has entered into a set of definitive agreements to acquire EOFlow Co. Ltd., manufacturer of the EOPatch® device - a tubeless, wearable and fully disposable insulin delivery device.